Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
XETRA:HPHA
Price:
3.05
EUR
Market Cap:
€142.7m
Relative Value
The Relative Value of one
HPHA
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 3.05 EUR,
Heidelberg Pharma AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HPHA Relative Value
HIDDEN
Multiples Across Competitors
HPHA Competitors Multiples
Heidelberg Pharma AG Competitors
Heidelberg Pharma AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Heidelberg Pharma AG
XETRA:HPHA
|
142.7m EUR | 47 | -5.5 | -5.9 | -5.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.6B USD | 6.5 | 94.4 | 15.5 | 21.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.9B USD | 5.4 | 25.9 | 14.8 | 14.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.2B USD | 6.2 | 21.3 | 13.3 | 16.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.5B USD | 10.1 | 30.6 | 23.1 | 24.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.1 | 34.5 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
37.8B EUR | 10.8 | 34.6 | 37.5 | 38.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
